Literature DB >> 10948152

Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide.

R Dziarski1, S Viriyakosol, T N Kirkland, D Gupta.   

Abstract

The purpose of this study was to identify the functional significance of the binding of soluble CD14 (sCD14) to bacterial peptidoglycan (PGN) and to compare the structural requirements of sCD14 for the binding to PGN and lipopolysaccharide (LPS) and for sCD14-mediated enhancement of PGN- and LPS-induced cell responses. sCD14 did not facilitate the responses of membrane CD14 (mCD14)-negative pre-B 70Z/3 cells to PGN, although it facilitated the responses of these cells to LPS and although mCD14 facilitated the responses of 70Z/3 cells to PGN. sCD14 enhanced mCD14-mediated cell activation by both PGN and LPS, but only the responses to LPS, and not to PGN, were enhanced by LPS-binding protein. Four 4- or 5-amino-acid-long sequences within the 65-amino-acid N-terminal region of sCD14 were needed for binding to both PGN and LPS and for enhancement of cell activation by both PGN and LPS. However, deletions of individual sequences had different effects on the ability of sCD14 to bind to PGN and to LPS and on the ability to enhance the responses to PGN and to LPS. Thus, there are different structural requirements of sCD14 for binding to PGN and to LPS and for the enhancement of PGN- and LPS-induced cell activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948152      PMCID: PMC101786          DOI: 10.1128/IAI.68.9.5254-5260.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide.

Authors:  S Viriyakosol; J C Mathison; P S Tobias; T N Kirkland
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

3.  CD14 employs hydrophilic regions to "capture" lipopolysaccharides.

Authors:  M D Cunningham; R A Shapiro; C Seachord; K Ratcliffe; L Cassiano; R P Darveau
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

4.  Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.

Authors:  B Yu; S D Wright
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

Review 5.  Isolation of peptidoglycan and soluble peptidoglycan fragments.

Authors:  R S Rosenthal; R Dziarski
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.

Authors:  E Hailman; T Vasselon; M Kelley; L A Busse; M C Hu; H S Lichenstein; P A Detmers; S D Wright
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

7.  Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.

Authors:  P S Tobias; K Soldau; J A Gegner; D Mintz; R J Ulevitch
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

8.  Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.

Authors:  T S Juan; E Hailman; M J Kelley; L A Busse; E Davy; C J Empig; L O Narhi; S D Wright; H S Lichenstein
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.

Authors:  B Weidemann; H Brade; E T Rietschel; R Dziarski; V Bazil; S Kusumoto; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  A region of human CD14 required for lipopolysaccharide binding.

Authors:  S Viriyakosol; T N Kirkland
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

View more
  9 in total

1.  Establishment of the cell line, HeLa-CD14, transfected with the human CD14 gene.

Authors:  Bo-Tao Ning; Yong-Min Tang
Journal:  Oncol Lett       Date:  2012-01-09       Impact factor: 2.967

2.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi.

Authors:  Zhihui Zhao; Rhonda Fleming; Bilaal McCloud; Mark S Klempner
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

4.  Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia.

Authors:  Nilufer Esen; Tammy Kielian
Journal:  J Neuroimmunol       Date:  2005-10-17       Impact factor: 3.478

5.  Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14.

Authors:  Seth Albright; Bin Chen; Kristen Holbrook; Nitin U Jain
Journal:  Biochem Biophys Res Commun       Date:  2008-01-28       Impact factor: 3.575

6.  Divergent responses to peptidoglycans derived from different E. coli serotypes influence inflammatory outcome in trout, Oncorhynchus mykiss, macrophages.

Authors:  Sebastian Boltaña; Felipe Reyes-Lopez; Davinia Morera; Frederick Goetz; Simon A MacKenzie
Journal:  BMC Genomics       Date:  2011-01-14       Impact factor: 3.969

7.  The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.

Authors:  D Muhvić; V El-Samalouti; H D Flad; B Radosević-Stasić; D Rukavina
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

8.  Transcription Factor SP2 Enhanced the Expression of Cd14 in Colitis-Susceptible C3H/HeJBir.

Authors:  Nils-Holger Zschemisch; Inga Brüsch; Anne-Sophie Hambusch; André Bleich
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

9.  Uptake, recognition and responses to peptidoglycan in the mammalian host.

Authors:  Paulo A D Bastos; Richard Wheeler; Ivo G Boneca
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.